Trials / Recruiting
RecruitingNCT05482607
Evaluation of HRCT Patterns in Systemic Sclerosis-associated Interstitial Lung Disease
Unsupervised Clustering Evaluation of HRCT Patterns in Systemic Sclerosis-associated Interstitial Lung Disease
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Systemic sclerosis (SSc) is a heterogeneous systemic autoimmune disease with distinct prognosis according to patients. Interstitial lung disease (ILD) concerns almost 50 % of SSc patients and represents the main cause of mortality. SSc-ILD is variable: from limited forms (with asymptomatic patients) to extensive lesions. Disease course in SSc-ILD is also highly variable: patients can experience stable disease, slow or fast progression. Investigators performed unsupervised clustering analysis to classify SSc-ILD according to elementary radiological lesions on HRCT scan.
Conditions
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2025-10-01
- Completion
- 2025-10-01
- First posted
- 2022-08-01
- Last updated
- 2024-08-27
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05482607. Inclusion in this directory is not an endorsement.